See more : Godrej Consumer Products Limited (GODREJCP.BO) Income Statement Analysis – Financial Results
Complete financial analysis of California Resources Corporation (CRC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of California Resources Corporation, a leading company in the Oil & Gas Exploration & Production industry within the Energy sector.
You may be interested
- Nippon Care Supply Co., Ltd. (2393.T) Income Statement Analysis – Financial Results
- The Charles Schwab Corporation (SCHW-PJ) Income Statement Analysis – Financial Results
- REA Group Limited (REA.AX) Income Statement Analysis – Financial Results
- Innocean Worldwide Inc. (214320.KS) Income Statement Analysis – Financial Results
- Karo Pharma AB (publ) (KARBF) Income Statement Analysis – Financial Results
California Resources Corporation (CRC)
About California Resources Corporation
California Resources Corporation operates as an independent oil and natural gas company. The company explores for, produces, gathers, processes, and markets crude oil, natural gas, and natural gas liquids for marketers, California refineries, and other purchasers that have access to transportation and storage facilities. As of December 31, 2021, it had interests in approximately 1.9 million net mineral acres with proved reserves totaled an estimated 480 million barrels of oil equivalent. The company also engages in the generation and sale of electricity to the local utility and the grid. The company was incorporated in 2014 and is based in Santa Clarita, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.81B | 3.26B | 2.57B | 1.61B | 2.69B | 3.06B | 2.10B | 1.75B | 2.40B | 4.17B | 4.29B | 4.07B | 3.94B |
| Cost of Revenue | 1.41B | 1.47B | 1.29B | 1.30B | 1.46B | 1.41B | 1.42B | 1.36B | 1.96B | 2.22B | 2.21B | 2.15B | 1.75B |
| Gross Profit | 1.41B | 1.79B | 1.28B | 308.00M | 1.23B | 1.65B | 676.00M | 394.00M | 448.00M | 1.95B | 2.08B | 1.93B | 2.19B |
| Gross Profit Ratio | 49.95% | 54.79% | 49.71% | 19.14% | 45.79% | 53.84% | 32.25% | 22.48% | 18.64% | 46.78% | 48.42% | 47.34% | 55.59% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 267.00M | 222.00M | 200.00M | 252.00M | 290.00M | 299.00M | 259.00M | 248.00M | 354.00M | 336.00M | 326.00M | 273.00M | 287.00M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 267.00M | 222.00M | 200.00M | 252.00M | 290.00M | 299.00M | 259.00M | 248.00M | 354.00M | 336.00M | 326.00M | 273.00M | 287.00M |
| Other Expenses | 330.00M | 257.00M | 202.00M | 155.00M | 455.00M | -23.00M | -7.00M | 30.00M | 392.00M | 563.00M | 302.00M | 445.00M | 261.00M |
| Operating Expenses | 597.00M | 479.00M | 402.00M | 407.00M | 745.00M | 881.00M | 523.00M | 494.00M | 746.00M | 899.00M | 628.00M | 718.00M | 548.00M |
| Cost & Expenses | 2.01B | 1.95B | 1.69B | 1.71B | 2.21B | 2.30B | 1.94B | 1.85B | 2.70B | 3.12B | 2.84B | 2.86B | 2.30B |
| Interest Income | 0.00 | 53.00M | 54.00M | 217.00M | 383.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 56.00M | 53.00M | 54.00M | 217.00M | 383.00M | 379.00M | 343.00M | 328.00M | 326.00M | 72.00M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 225.00M | 241.00M | 263.00M | 362.00M | 514.00M | 545.00M | 571.00M | 562.00M | 1.00B | 1.20B | 1.14B | 926.00M | 675.00M |
| EBITDA | 1.08B | 1.31B | 871.00M | 2.45B | 997.00M | 1.35B | 652.00M | 1.08B | -4.14B | -1.05B | 2.73B | 2.14B | 2.39B |
| EBITDA Ratio | 38.22% | 40.15% | 33.96% | -11.68% | 15.45% | 24.32% | 32.92% | 27.90% | 231.29% | 135.47% | 60.47% | 53.15% | 58.81% |
| Operating Income | 808.00M | 1.11B | 658.00M | -1.89B | -55.00M | 769.00M | 63.00M | -306.00M | -122.00M | -2.35B | 1.45B | 1.18B | 1.64B |
| Operating Income Ratio | 28.72% | 34.07% | 25.65% | -117.15% | -2.04% | 25.11% | 3.01% | -17.46% | -5.08% | -56.29% | 33.77% | 29.00% | 41.67% |
| Total Other Income/Expenses | -60.00M | -51.00M | -64.00M | 2.02B | -329.00M | -107.00M | -403.00M | 494.00M | -5.35B | -3.40B | -140.00M | -41.00M | 0.00 |
| Income Before Tax | 748.00M | 761.00M | 229.00M | 1.87B | 100.00M | 429.00M | -262.00M | 201.00M | -5.48B | -2.42B | 1.45B | 1.18B | 1.64B |
| Income Before Tax Ratio | 26.59% | 23.36% | 8.93% | 116.28% | 3.71% | 14.01% | -12.50% | 11.47% | -227.88% | -58.02% | 33.77% | 29.00% | 41.67% |
| Income Tax Expense | 184.00M | 237.00M | -396.00M | -1.46B | 1.00M | 101.00M | 340.00M | -78.00M | -1.92B | -987.00M | 578.00M | 482.00M | 670.00M |
| Net Income | 564.00M | 524.00M | 612.00M | 3.34B | 99.00M | 328.00M | -266.00M | 279.00M | -3.55B | -1.43B | 869.00M | 699.00M | 971.00M |
| Net Income Ratio | 20.05% | 16.08% | 23.86% | 207.27% | 3.68% | 10.71% | -12.69% | 15.92% | -147.90% | -34.36% | 20.28% | 17.16% | 24.66% |
| EPS | 8.10 | 6.94 | 7.46 | 40.03 | 2.02 | 6.92 | -6.26 | 6.76 | -92.79 | -37.54 | 17.31 | 13.93 | 2.51 |
| EPS Diluted | 7.78 | 6.75 | 7.37 | 40.03 | 2.02 | 6.92 | -6.26 | 6.76 | -92.79 | -37.54 | 17.31 | 13.93 | 2.51 |
| Weighted Avg Shares Out | 69.60M | 75.50M | 82.00M | 83.32M | 49.00M | 47.40M | 42.49M | 40.40M | 38.30M | 38.20M | 49.40M | 49.40M | 387.00M |
| Weighted Avg Shares Out (Dil) | 72.50M | 77.60M | 83.00M | 83.32M | 49.00M | 47.40M | 42.50M | 40.40M | 38.30M | 38.20M | 49.40M | 49.40M | 387.00M |
California Resources (CRC) Concludes Merger With Aera Energy
California Resources (CRC) expects capital expenditure to be in the $170-$210 million range for the combined entity and net daily production in the band of 140-146 mboe per day for second-half 2024.
Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI® (adagrasib) in Combination with Cetuximab for Adult Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer (CRC)
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BristolMyersSquibb--Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI® (adagrasib) in Combination with Cetuximab for Adult Patients with.
California Resources Corporation Announces Pricing of Upsized Private Offering of $600 Million of Senior Unsecured Notes
LONG BEACH, Calif.--(BUSINESS WIRE)--California Resources Corporation (NYSE: CRC) (the “Company”) announced today the pricing of its upsized private offering of $600 million in aggregate principal amount of its 8.250% senior unsecured notes due 2029 (the “Notes”) at par. The Notes...
California Resources Corporation Announces Private Offering of $500 Million of Senior Unsecured Notes
LONG BEACH, Calif.--(BUSINESS WIRE)--California Resources Corporation (NYSE: CRC) (the “Company”) announced today that, subject to market and other conditions, it intends to offer and sell to eligible purchasers $500 million in aggregate principal amount of senior unsecured notes due 2029...
Subang Jaya Medical Centre Applauded by Frost & Sullivan as the Best Hospital Company of the Year in Malaysia for the fourth consecutive year
SJMC's significant efforts in alleviating nursing shortages, enhancing workflows and its strong market-leading position, both locally and globally resulted in high patient retention and strong referrals. SAN ANTONIO, May 19, 2024 /PRNewswire/ -- Frost & Sullivan recently analyzed the hospital...
California Resources Corporation (CRC) Q1 2024 Earnings Call Transcript
California Resources Corporation (NYSE:CRC ) Q1 2024 Earnings Conference Call May 8, 2024 1:00 PM ET Company Participants Joanna Park - Vice President-Investor Relations and Treasurer Francisco Leon - Chief Executive Officer Nelly Molina - Chief Financial Officer Chris Gould...
California Resources Reports First Quarter 2024 Financial and Operating Results
LONG BEACH, Calif.--(BUSINESS WIRE)--California Resources Corporation (NYSE: CRC) today reported financial and operating results for the first quarter 2024. The Company plans to host a conference call and webcast on Wednesday, May 8th at 1:00 p.m. Eastern Time (10:00 a.m....
Carbon TerraVault Provides First Quarter 2024 Update
LONG BEACH, Calif.--(BUSINESS WIRE)--Carbon TerraVault (CTV) today provided an update on its first quarter 2024 operations. California Resources Corporation (NYSE: CRC) conducts its carbon management business through CTV which pursues carbon capture and sequestration (CCS) projects that are directly sited...
MICHAEL ABONEKA: Forceful and harmful circumcision is a violation of the rights of a boy child
Uganda ratified the United Nations Convention on the Rights of the Child(CRC) and the African Charter on the Rights and Welfare of the Child (ACRWC) which mandate Uganda to protect the rights and interests of children without discrimination. Articles 3...
California Resources Corporation (CRC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
California Resources (CRC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Source: https://incomestatements.info
Category: Stock Reports